Search Filters

Search Results

Found 8 results

510(k) Data Aggregation

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner's hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs, fentanyl citrate, xylazine, gastric acid, fentanyl in gastric acid and xylazine in gastric acid in accordance with ASTM D6978-05 Standard Practice for Assessment of Resistance of Medical gloves to Permeation by Chemotherapy Drugs.

    Warning: do not use with Carmustine and Thiotepa.

    The maximum testing time is 240 minutes. Please note that the following drug has an extremely low permeation time:

    • Carmustine (BCNU) 3.3 mg/ml 21.5 minutes
    • Thiotepa 10.0 mg/ml 13.6 minutes
    Device Description

    "Disposable Powder Free Nitrile Examination Glove, Blue Color, Tested For Use With Chemotherapy Drugs, Fentanyl Citrate, Xylazine, Gastric acid, Fentanyl in Gastric acid and Xylazine in Gastric acid" is a patient examination glove made from nitrile compound, non-sterile (as per 21 CFR 880.6250, Class I). The principle operation of this medical device is to provide single use barrier protection for the wearer and the device meets the specifications for Barrier Protection and tensile properties as defined in ASTM D6319-19, Standard specification for Nitrile Examination Gloves.

    AI/ML Overview

    The provided document is an FDA 510(k) clearance letter for a medical device: "Disposable Powder Free Nitrile Examination Glove, Blue Color, Tested For Use With Chemotherapy Drugs, Fentanyl Citrate, Xylazine, Gastric acid, Fentanyl in Gastric acid and Xylazine in Gastric acid."

    This is a physical medical device (a glove), not a software device or an AI/ML algorithm. Therefore, many of the requested categories related to AI/ML model validation (e.g., sample size for test set, data provenance, number of experts for ground truth, adjudication methods, MRMC studies, standalone performance, training set details) are not applicable to this type of FDA submission.

    The document assesses the device's physical properties and its resistance to permeation by various hazardous substances. The "acceptance criteria" and "study that proves the device meets the acceptance criteria" refer to bench testing against established ASTM and CFR standards for medical gloves.

    Here's the breakdown of the relevant information from the document, tailored to the nature of this device:


    Acceptance Criteria and Device Performance for Disposable Nitrile Examination Gloves

    1. Table of Acceptance Criteria and Reported Device Performance

    The device (Disposable Powder Free Nitrile Examination Glove, Blue Color) was tested against several physical and chemical permeation standards. The acceptance criteria and results are outlined in the "Assessment of Non-Clinical Performance Data" section (Page 17-19) and the "Indications for Use" section (Page 4-5) and summarized within the "510(k) Summary" (Page 7-11).

    TestTest MethodPurposeAcceptance CriteriaResults
    DimensionASTM D6319-19Determine the geometrical dimension of glovesLength: Short cuff: ≥230mm; Long cuff: ≥300mmThickness: Palm: ≥ 0.05 mm; Finger: ≥ 0.05 mm; Cuff: ≥ 0.05 mmPalm Width: XS: 70 ± 10 mm; S: 80 ± 10 mm; M: 95 ± 10 mm; L: 110 ± 10 mm; XL: 120 ± 10 mmPass
    Freedom from holes (Water leak)21 CFR 800.20. & ASTM D5151-19Detect the holes on the gloves.G-I/ AQL 2.5Pass
    Tensile strength (Before aging/ After aging)ASTM D6319-19Evaluate the tensile (tension) properties of the gloves. In addition, it also determines the influence of elevated temperature on the physical properties of gloves.Before Aging: ≥14MPaAfter Aging: ≥14MPaPass
    Elongation (Before aging/ After aging)ASTM D6319-19Related to tensile properties, measures stretchiness.Before Aging: ≥500%After Aging: ≥400%Pass
    Powder ResidualASTM D6319-19Determine the average powder mass found on the gloves< 2mg per glovePass
    Biocompatibility - CytotoxicityAAMI/ANSI/ISO 10993-5Determine the cytotoxicity potential of gloveNo in vitro cytotoxic as described in ISO 10993-5Pass
    Biocompatibility - Skin Sensitization and IrritationAAMI/ANSI/ISO 10993-10Determine the potential of glove to promote skin sensitization after repeated applications.Determine the potential of gloves to promote skin irritation after repeated applications.No dermal reactions indicative of delayed contact hypersensitivityNo skin irritation, cumulative irritation index to be 0.Pass
    Resistance of Gloves to Permeation by Chemotherapy and Other Liquid Hazardous Drugs, and Non-drugs SolutionASTM D6978-05Assessment of medical gloves to permeation by chemotherapy and other liquid hazardous drugs, and non-drugs solution.The resistance of the device to permeation were challenged against 59 hazardous drugs and 1 non-drugs simulated solution. General Acceptance Standard (Implicit): Maintain barrier protection for a minimum period. The tables on pages 4-5 and 7-11 list Minimum Breakthrough Detection Time (Min.) for each substance. For most substances, the acceptance criterion was ">240 minutes", meaning no breakthrough occurred within the 240-minute test period. For Carmustine and Thiotepa, specific breakthrough times (21.5 and 13.6 minutes, respectively) were observed and noted as limitations/warnings.Pass

    2. Sample size used for the test set and the data provenance:

    • Sample Size: The document does not explicitly state numerical sample sizes for each specific test (e.g., how many gloves were tested for a burst, tensile, or permeation). However, it implies that testing was conducted according to the specified ASTM and FDA methodologies, which inherently define minimum sample sizes for material testing (e.g., AQL levels for freedom from holes).
    • Data Provenance: The tests are "bench testing" conducted on physical glove samples. The manufacturer is "Ever Global (Vietnam) Enterprise Corporation" from Vietnam, so the testing was likely conducted in accordance with international standards at a facility associated with the manufacturer or a certified testing lab. The data is non-clinical performance data from laboratory experiments, not patient data.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Not Applicable. As this is a physical device subject to material property and permeation testing, "ground truth" is established by adherence to physical measurement standards and chemical analysis protocols (e.g., ASTM D6319-19 for physical properties, ASTM D6978-05 for permeation). No human expert interpretation or consensus is required to establish the "truth" of a chemical breakthrough time or tensile strength value.

    4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

    • Not Applicable. Adjudication methods are relevant in subjective human interpretation tasks (e.g., radiology image reading). For objective bench testing of physical properties, results are determined by instrumentation and adherence to standardized protocols, not human adjudication.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • Not Applicable. MRMC studies are used for evaluating the impact of AI on human reader performance, typically in medical imaging. This is a physical glove, not an AI-assisted diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    • Not Applicable. This is a physical device, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):

    • The "ground truth" is established through objective, standardized laboratory measurement methods as defined by the referenced ASTM (American Society for Testing and Materials) and CFR (Code of Federal Regulations) standards.
      • For physical properties (Dimensions, Tensile Strength, Elongation, Powder Residual, Freedom from Holes), the ground truth is the measured physical values against the defined thresholds in ASTM D6319-19 and 21 CFR 800.20 & ASTM D5151-19.
      • For chemical permeation (Resistance to Hazardous Drugs), the ground truth is the measured breakthrough time determined by chemical analysis according to ASTM D6978-05.
      • For Biocompatibility, the ground truth is the biological response (cytotoxicity, dermal reactions) as measured per AAMI/ANSI/ISO 10993-5 and 10993-10 standards.

    8. The sample size for the training set:

    • Not Applicable. This is a physical product, not a machine learning model; therefore, there is no "training set." The product's design and manufacturing process are developed through engineering and material science, not data training.

    9. How the ground truth for the training set was established:

    • Not Applicable. As there is no training set for this physical device.
    Ask a Question

    Ask a specific question about this device

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner's hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs, fentanyl citrate, and xylazine in accordance with ASTM D6978-05 Standard Practice for Assessment of Resistance of Medical gloves to Permeation by Chemotherapy Drugs.

    Device Description

    "Disposable Powder Free Nitrile Examination Glove, Blue Color, Tested For Use With Chemotherapy Drugs And Fentanyl Citrate And Xylazine" is a patient examination glove made from nitrile compound, non-sterile (as per 21 CFR 880.6250, Class I). The principle operation of this medical device is to provide single use barrier protection for the wearer and the device meets the specifications for Barrier Protection and tensile properties as defined in ASTM D6319-19, Standard specification for Nitrile Examination Gloves.

    AI/ML Overview

    The provided document is a 510(k) Premarket Notification for a Disposable Powder Free Nitrile Examination Glove, Blue Color, Tested For Use With Chemotherapy Drugs and Fentanyl Citrate and Xylazine.

    This device is a Class I medical device (non-powered patient examination glove). For devices in this class, the FDA typically does not require a clinical performance study with human subjects. Instead, evidence of substantial equivalence to a predicate device is primarily demonstrated through non-clinical performance data (bench testing).

    Therefore, the requested information regarding AI device acceptance criteria, MRMC studies, ground truth establishment, training sets, and expert adjudication are not applicable to this particular device submission. This document describes the performance of a physical examination glove, not an AI or imaging device.

    However, I can extract the acceptance criteria and reported device performance from the non-clinical testing:

    Acceptance Criteria and Reported Device Performance

    The study aims to demonstrate that the subject device (Disposable Powder Free Nitrile Examination Glove, Blue Color, Tested For Use With Chemotherapy Drugs and Fentanyl Citrate and Xylazine) meets the acceptance criteria for various physical and chemical resistance properties, establishing its substantial equivalence to a predicate device (K193555).

    Here is a table summarizing the acceptance criteria and the device's reported performance:

    TestTest MethodAcceptance CriteriaReported Device Performance
    DimensionASTM D6319-19Length:Short cuff: ≥230mmLong cuff: ≥300mmThickness:Palm: ≥ 0.05 mmFinger: ≥ 0.05 mmCuff: ≥ 0.05 mmPalm Width:XS: 70 ± 10 mm;S: 80 ± 10 mm;M: 95 ± 10 mm;L: 110 ± 10 mm;XL: 120 ± 10 mmPass
    Freedom from holes (Water leak)21 CFR 800.20 & ASTM D5151-19G-I/ AQL 2.5Pass
    Tensile strength (Before aging/ After aging)ASTM D6319-19Before Aging: ≥14MPaAfter Aging: ≥14MPaPass
    Elongation (Before aging/ After aging)ASTM D6319-19Before Aging: ≥500%After Aging: ≥400%Pass
    Powder ResidualASTM D6319-19< 2mg per glovePass
    Biocompatibility - CytotoxicityAAMI/ANSI/ISO 10993-5No in vitro cytotoxic as described in ISO 10993-5Pass
    Biocompatibility - Skin Sensitization and IrritationAAMI/ANSI/ISO 10993-10No dermal reactions indicative of delayed contact hypersensitivityNo skin irritation, cumulative irritation index to be 0.Pass
    Resistance of Gloves to Permeation by Chemotherapy DrugsASTM D6978-05The resistance of the device to permeation were challenged against 57 liquid hazardous drugs. The target for most drugs (55 out of 57) was >240 minutes minimum breakthrough detection time. For Carmustine (BCNU) and Thiotepa, specific lower breakthrough times were accepted (21.5 minutes and 13.6 minutes, respectively), with warnings provided. For Xylazine, no breakthrough was detected for up to 240 minutes.Pass (as detailed in the tables for each drug)

    Regarding the specific questions about AI/imaging studies:

    • 2. Sample size used for the test set and the data provenance: Not applicable. This refers to physical tests on glove samples.
    • 3. Number of experts used to establish the ground truth... and their qualifications: Not applicable. Ground truth for physical properties is established by standardized testing methods.
    • 4. Adjudication method (e.g., 2+1, 3+1, none) for the test set: Not applicable. Results are quantitative measurements from lab tests.
    • 5. If a multi reader multi case (MRMC) comparative effectiveness study was done...: Not applicable. This is not an AI or imaging device.
    • 6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. This is not an algorithm.
    • 7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): The "ground truth" for this device's performance is established through adherence to recognized international/national standards for medical glove testing (e.g., ASTM D6319-19, ASTM D5151-19, ASTM D6978-05, AAMI/ANSI/ISO 10993-5, AAMI/ANSI/ISO 10993-10). These standards define the test methods and performance requirements.
    • 8. The sample size for the training set: Not applicable. This is a manufactured product, not an AI model.
    • 9. How the ground truth for the training set was established: Not applicable. Manufacturing controls and quality assurance ensure consistency, not a "training set" in the context of AI.
    Ask a Question

    Ask a specific question about this device

    K Number
    K221980
    Date Cleared
    2023-02-06

    (216 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A non-powdered patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.

    Device Description

    A Disposable Powder Free Vinyl Examination Gloves (with color Beige or Clear) is a patient examination glove made from poly (vinvl chloride), non-sterile (as per 21 CFR 880.6250, Class I). The operation principle of this medical device is to provide single use barrier protection for the wearer and the device meets all the requirement specifications for barrier protection, tensile properties as defined in ASTM D5250-19, Standard Specification for Poly (vinyl chloride) Gloves for Medical Application.

    AI/ML Overview

    The document provides information about the non-clinical performance evaluation of "Disposable Powder Free Vinyl Examination Gloves, Beige/Clear" to demonstrate its substantial equivalence to a predicate device.

    Here's a breakdown of the requested information based on the provided text:

    1. A table of acceptance criteria and the reported device performance

    TestTest MethodPurposeAcceptance CriteriaReported Device Performance
    DimensionASTM D3767Determine the geometrical dimension of glovesLength: 230 mm min.Pass
    Thickness: Palm - 0.08 mm min., Finger - 0.08 mm min.Pass
    Palm Width: Small 85 ± 5 mm, Medium 95 ± 5 mm, Large 105 ± 5 mm, X Large 115 ± 5 mmPass
    Freedom from holes (Water leak)21 CFR 800.20. & ASTM D5151-19Detect the holes on the gloves.G-I/AQL 2.5Pass
    Tensile strength (Before/After aging)ASTM D412-16 & ASTM D573-04Evaluate the tensile (tension) properties of the gloves. In addition, it also determines the influence of elevated temperature on the physical properties of gloves.Before Aging: 11 MPa, min.Pass
    After Aging: 11 MPa, min.Pass
    Elongation (Before/After aging)ASTM D412-16 & ASTM D573-04(purpose as above for tensile strength)Before Aging: 300% min.Pass
    After Aging: 300% min.Pass
    Powder ResidualASTM D6124-06Determine the average powder mass found on the gloves< 2mg per glovePass
    Biocompatibility-Skin IrritationISO 10993-10:2010Determine the potential of glove to promote skin sensitization & irritation reactions after repeated applicationsNegative ResponsePass
    Biocompatibility-Skin SensitizationISO 10993-10:2010(purpose as above for skin irritation)No contact sensitizationPass
    Biocompatibility-cytotoxicityISO 10993-5:2009Determine the cytotoxicity potential of gloveNo in vitro cytotoxicityPass

    2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)

    The document does not explicitly state the sample sizes used for each specific test. For instance, for "Freedom from holes," it mentions "G-I/AQL 2.5," which implies a sampling plan, but the exact number of units tested is not provided. The data provenance is not specified beyond being "nonclinical bench testing" conducted by the manufacturer. It does not mention countries of origin for the data or whether it was retrospective or prospective, as these are typically not applicable to bench testing of this nature.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)

    This section is not applicable as the study involves non-clinical bench testing of physical and chemical properties of gloves, not medical image analysis or diagnostic performance requiring expert interpretation. The "ground truth" is established by adherence to recognized international standards (ASTM, ISO) for material properties.

    4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

    This is not applicable as the tests are objective, quantitative measurements against predefined criteria as per ASTM and ISO standards, not subjective assessments requiring adjudication by multiple readers.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This is not applicable as the device is a medical glove, a physical product, and does not involve AI assistance or human reader interpretation.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

    This is not applicable as the device is a medical glove, not an algorithm or AI system.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    The ground truth for this device is based on established international standards and specifications for medical gloves, specifically:

    • ASTM D3767 (Dimensions)
    • 21 CFR 800.20 & ASTM D5151-19 (Freedom from holes)
    • ASTM D412-16 & ASTM D573-04 (Tensile strength and Elongation)
    • ASTM D6124-06 (Powder Residual)
    • ISO 10993-10:2010 (Skin Irritation and Sensitization)
    • ISO 10993-5:2009 (Cytotoxicity)

    These standards define the acceptable physical properties and biocompatibility.

    8. The sample size for the training set

    This is not applicable as this study is a non-clinical performance evaluation of a medical device (glove) against established standards, not a machine learning or AI algorithm that requires a training set.

    9. How the ground truth for the training set was established

    This is not applicable for the same reason as point 8.

    Ask a Question

    Ask a specific question about this device

    K Number
    K220992
    Date Cleared
    2022-10-19

    (198 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A non-powdered patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.

    Device Description

    A Disposable Powder Free Vinyl Exam Glove (with color Black, Blue, or Purple) is a patient examination glove made from poly (vinyl chloride), non-sterile (as per 21 CFR 880.6250, Class I). This device is available in size S, M, L, and XL. The operation principle of this medical device is to provide single use barrier protection for the wearer and the device meets all the requirement specifications for barrier protection, tensile properties as defined in ASTM D5250-19, Standard Specification for Poly (vinyl chloride) Gloves for Medical Application.

    AI/ML Overview

    The provided text describes the acceptance criteria and the results of non-clinical performance testing for a medical device, specifically Disposable Powder Free Vinyl Exam Gloves.

    Here's a breakdown of the requested information:

    1. A table of acceptance criteria and the reported device performance

    TestAcceptance CriteriaReported Device Performance
    DimensionLength: 230 mm min.Thickness:- Palm - 0.08 mm min.- Finger - 0.08 mm min.Palm Width:- Small 85 ± 5 mm- Medium 95 ± 5 mm- Large 105 ± 5 mm- X Large 115 ± 5 mmPass
    Freedom from holes (Water leak)G-I/AQL 2.5Pass
    Tensile strengthBefore Aging: 11 MPa, min.After Aging: 11 MPa, min.Pass
    ElongationBefore Aging: 300% min.After Aging: 300% min.Pass
    Powder Residual< 2mg per glovePass
    Biocompatibility - Skin IrritationNegative ResponsePass
    Biocompatibility - Skin SensitizationNo contact sensitizationPass
    Biocompatibility - CytotoxicityNo in vitro cytotoxicityPass

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document does not explicitly state the sample size used for each specific test or the data provenance. It only states "Pass" for each criterion, indicating that the tests were conducted.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This information is not applicable as the acceptance criteria are based on standardized test methods and physical/chemical properties, not on expert interpretation of medical images or patient data.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This information is not applicable as the assessment involves standardized laboratory tests with objective measurements, not expert adjudication of subjective findings.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This information is not applicable. The device is a physical product (examination gloves), not an AI-assisted diagnostic tool. Therefore, an MRMC study is irrelevant.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

    This information is not applicable. The device is a physical product, not a standalone algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The "ground truth" for the performance evaluation of these gloves is based on established international and national standards for physical, chemical, and biological properties of medical gloves. Specifically, the tests reference:

    • ASTM D3767 (for Dimension)
    • 21 CFR 800.20 & ASTM D5151-19 (for Freedom from holes)
    • ASTM D412-16 & ASTM D573-04 (for Tensile strength & Elongation)
    • ASTM D6124-06 (for Powder Residual)
    • ISO 10993-10:2010 and ISO 10993-23:2021 (for Biocompatibility - Skin Irritation and Sensitization)
    • ISO 10993-5:2009 (for Biocompatibility - Cytotoxicity)

    These standards define the acceptable range or condition for each characteristic.

    8. The sample size for the training set

    This information is not applicable. The described study is a non-clinical performance evaluation against predetermined standards, not a machine learning model requiring a training set.

    9. How the ground truth for the training set was established

    This information is not applicable for the same reasons as point 8.

    Ask a Question

    Ask a specific question about this device

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner's hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs and fentanyl citrate in accordance with ASTM D6978-05 Standard Practice for Assessment of Resistance of Medical gloves to Permeation by Chemotherapy Drugs.

    Device Description

    "Disposable Powder Free Nitrile Examination Glove, Blue Color, Tested For Use With Chemotherapy Drugs And Fentanyl Citrate" is a patient examination glove made from nitrile compound, non-sterile (as per 21 CFR 880.6250, Class I). The principle operation of this medical device is to provide single use barrier protection for the wearer and the device meets the specifications for Barrier Protection and tensile properties as defined in ASTM D6319-10, Standard specification for Nitrile Examination Gloves.

    AI/ML Overview

    This document describes the premarket notification (510(k)) for a medical device: "Disposable Powder Free Nitrile Examination Glove, Blue Color, Tested For Use With Chemotherapy Drugs and Fentanyl Citrate" (K193555). The core of the submission, as it relates to proving the device meets acceptance criteria, focuses on the glove's resistance to permeation by chemotherapy drugs and fentanyl citrate.

    Here's an analysis of the provided information to answer your questions:

    1. A table of acceptance criteria and the reported device performance

    The primary acceptance criteria for the chemotherapy drug and fentanyl citrate resistance are the "Minimum Breakthrough Detection Time (Min.)" as per ASTM D6978-05. The device aims to achieve a breakthrough time of "> 240 minutes" for most listed drugs.

    Test Chemotherapy Drug / Fentanyl CitrateConcentration (mg/ml or mcg/2mL)Acceptance Criteria (Minimum Breakthrough Detection Time)Reported Device Performance (Breakthrough Detection Time - Short Cuff)Reported Device Performance (Breakthrough Detection Time - Long Cuff)
    Arsenic Trioxide1.0> 240 min> 240 minN/A
    Azacitidine (Vidaza)25.0> 240 min> 240 minN/A
    Bendamustine HCl5.0> 240 min> 240 minN/A
    Bleomycin Sulfate15.0> 240 min> 240 minN/A
    Bortezomib (Velcade)1.0> 240 min> 240 minN/A
    Busulfan6.0> 240 min> 240 minN/A
    Carboplatin10.0> 240 min> 240 minN/A
    Carfilzomib2.0> 240 min> 240 minN/A
    Carmustine (BCNU)3.3Not specified for new device directly, but predicate showed 6.2 min. New device aims to show improved or similar performance.21.5 min37.5 min
    Cetuximab (Erbitux)2.0> 240 min> 240 minN/A
    Chloroquine50.0> 240 min> 240 minN/A
    Cisplatin1.0> 240 min> 240 minN/A
    Cladribine1.0> 240 min> 240 minN/A
    Cyclophosphamide20.0> 240 min> 240 minN/A
    Cyclosporine A100.0> 240 min> 240 minN/A
    Cytarabine100.0> 240 min> 240 minN/A
    Cytovene (Ganciclovir)10.0> 240 min> 240 min (Found in Indications for Use table, not explicitly in the detailed comparison table)N/A
    Dacarbazine10.0> 240 min> 240 minN/A
    Daunorubicin5.0> 240 min> 240 minN/A
    Decitabine5.0> 240 min> 240 minN/A
    Docetaxel10.0> 240 min> 240 minN/A
    Doxorubicin Hydrochloride2.0> 240 min> 240 minN/A
    Epirubicin (Ellence)2.0> 240 min> 240 minN/A
    Etoposide20.0> 240 min> 240 minN/A
    Fludarabine25.0> 240 min> 240 minN/A
    Fluorouracil50.0> 240 min> 240 minN/A
    Fulvestrant50.0> 240 min> 240 minN/A
    Gemcitabine38.0> 240 min> 240 minN/A
    Idarubicin1.0> 240 min> 240 minN/A
    Ifosfamide50.0> 240 min> 240 minN/A
    Irinotecan20.0> 240 min> 240 minN/A
    Mechlorethamine HCl1.0> 240 min> 240 minN/A
    Melphalan5.0> 240 min> 240 minN/A
    Methotrexate25.0> 240 min> 240 minN/A
    Mesna100.0> 240 min> 240 minN/A
    Mitomycin C0.5> 240 min> 240 minN/A
    Mitoxantrone2.0> 240 min> 240 minN/A
    Oxaliplatin5.0> 240 min> 240 minN/A
    Paclitaxel6.0> 240 min> 240 minN/A
    Paraplatin10.0> 240 min> 240 minN/A
    Pemetrexed25.0> 240 min> 240 minN/A
    Pertuzumab30.0> 240 min> 240 minN/A
    Raltitrexed0.5> 240 min> 240 minN/A
    Retrovir10.0> 240 min> 240 minN/A
    Rituximab10.0> 240 min> 240 minN/A
    Temsirolimus25.0> 240 min> 240 minN/A
    Thiotepa10.0Not specified for new device directly, but predicate showed 38.8 min. New device aims to show improved or similar performance.23.1 min13.6 min
    Topotecan HCl1.0> 240 min> 240 minN/A
    Trastuzumab21.0> 240 min> 240 minN/A
    Triclosan2.0> 240 min> 240 minN/A
    Trisenox1.0> 240 min> 240 minN/A
    Vinblastine1.0> 240 min> 240 minN/A
    Vincristine Sulfate1.0> 240 min> 240 minN/A
    Vinorelbine10.0> 240 min> 240 minN/A
    Zoledronic Acid0.8> 240 min> 240 minN/A
    Fentanyl Citrate Injection100 mcg/2mL> 240 min> 240 minN/A

    Note on Acceptance Criteria: For most drugs, the stated acceptance criterion is explicitly given as "> 240 minutes" in the "Indications for Use" section and confirmed by the reported performance. For Carmustine and Thiotepa, the document highlights their "extremely low permeation time" and provides their specific breakthrough times. The comparison table (Table 2) then compares these to the predicate, showing the new device's performance. The "Warning: do not use with Carmustine and Thiotepa" statement effectively sets the acceptance criteria for these specific drugs as less than the ideal >240 minutes, acknowledging their known rapid permeation through gloves. The aim for these is to show performance comparable or better than the predicate, which the subject device achieves for Carmustine, but is slightly worse for Thiotepa (Thiotepa: predicate 38.8 min, subject device 23.1 min (short cuff) and 13.6 min (long cuff)). However, since a warning is issued, this outcome appears to be accepted.

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • Sample Size for Test Set: The document does not explicitly state the specific number of gloves/samples tested for each drug permeation. It refers to testing "in accordance with ASTM D6978-05 Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs," which would define the sample size requirements for the test. However, the exact sample numbers (e.g., how many gloves were tested for each drug) are not provided in this summary.
    • Data Provenance: The tests were conducted by Ever Global (Vietnam) Enterprise Corp (Vietnam). The type of study for these tests would be prospective bench testing, as new gloves were manufactured and then tested for their characteristics.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This is a device performance study based on laboratory bench testing, not an AI or diagnostic study involving expert interpretation of medical images. Therefore:

    • Number of experts: Not applicable. Ground truth for material properties (like drug permeation) is established through standardized laboratory procedures and measurements.
    • Qualifications of experts: Not applicable in the context of human expert review of "ground truth" for clinical data. The "experts" here would be the laboratory personnel qualified to perform ASTM D6978-05 and other relevant material testing standards.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. This is not a study involving human reader interpretation or adjudication. Device performance is determined by direct physical and chemical testing according to established ASTM standards.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This is a 510(k) submission for a physical medical device (gloves), not an AI-assisted diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is a physical device, not an algorithm. The "standalone performance" is the intrinsic material property of the glove against chemical permeation.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The "ground truth" for the device's performance regarding chemotherapy drug and fentanyl permeation is established through direct laboratory measurement using the methodology outlined in ASTM D6978-05. This standard defines how resistance to permeation is assessed, with breakthrough time being the key metric. For other properties like tensile strength, freedom from holes, powder residual, and biocompatibility, the ground truth is also established by specific ASTM standards and biological evaluation guidelines (e.g., ISO 10993).

    8. The sample size for the training set

    Not applicable. This is a traditional device submission, not an AI/machine learning product that requires a "training set." The gloves are manufactured, and then samples from the manufacturing batches are subjected to testing (the "test set" in this context).

    9. How the ground truth for the training set was established

    Not applicable, as there is no training set for this type of device submission.

    Ask a Question

    Ask a specific question about this device

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner's hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 Standard Practice for Assessment of Medical gloves to Permeation by Chemotherapy Drugs.

    Device Description

    Disposable Powder Free Nitrile Examination Glove, White/Blue Color, Tested For Use With Chemotherapy Drugs is a patient examination glove made from nitrile compound, non-sterile (as per 21 CFR 880.6250, Class I). The principle operation of the medical device to provide single use barrier protection for the wearer and the device meets all the requirement specifications for Barrier Protection, tensile properties as defined in ASTM D6319-10, Standard specification for Nitrile Examination Gloves.

    AI/ML Overview

    The provided text is a 510(k) summary for Disposable Powder Free Nitrile Examination Gloves, white and blue colors, tested for use with chemotherapy drugs. It focuses on the safety and effectiveness of the device through non-clinical testing and comparison to a predicate device.

    Here's an analysis to extract the requested information, noting that much of it pertains to AI/software device studies and is not applicable to this type of medical glove submission:

    1. A table of acceptance criteria and the reported device performance

    CharacteristicsStandard / Acceptance CriteriaReported Device Performance (White Gloves)Reported Device Performance (Blue Gloves)
    Chemotherapy Drug PermeationASTM D6978-05 Minimum Breakthrough Detection Time (Min)
    Carmustine (BCNU), 3.3 mg/ml- (No specific minimum listed, but tested)22.8 minutes6.2 minutes
    Thiotepa, 10.0 mg/ml- (No specific minimum listed, but tested)54.6 minutes38.8 minutes
    Cyclophosphamide (Cytoxan), 20.0 mg/ml≥ 240 minutes (Maximum testing time)≥ 240 minutes≥ 240 minutes
    Cisplatin, 1.0 mg/ml≥ 240 minutes (Maximum testing time)≥ 240 minutes≥ 240 minutes
    Doxorubicin Hydrochloride, 2.0 mg/ml≥ 240 minutes (Maximum testing time)≥ 240 minutes≥ 240 minutes
    Fluorouracil, 50.0 mg/ml≥ 240 minutes (Maximum testing time)≥ 240 minutes≥ 240 minutes
    Dacarbazine (DTIC), 10.0 mg/ml≥ 240 minutes (Maximum testing time)≥ 240 minutes≥ 240 minutes
    Etoposide (Toposar), 20.0 mg/ml≥ 240 minutes (Maximum testing time)≥ 240 minutes≥ 240 minutes
    Paclitaxel (Taxol), 6.0 mg/ml≥ 240 minutes (Maximum testing time)≥ 240 minutes≥ 240 minutes
    DimensionASTM D6319-10(Reapproved 2015)CompliesComplies
    Length≥ 230mmComplies (230 mm min)Complies (230 mm min)
    Width (Small)80 ±10 mmComplies (80 ±10 mm)Complies (80 ±10 mm)
    Width (Medium)95 ±10 mmComplies (95 ±10 mm)Complies (95 ±10 mm)
    Width (Large)110 ±10 mmComplies (110 ±10 mm)Complies (110 ±10 mm)
    Width (X-Large)120 ±10 mmComplies (120 ±10 mm)Complies (120 ±10 mm)
    Thickness (Finger tip)≥ 0.05mmComplies (≥ 0.05mm)Complies (≥ 0.05mm)
    Thickness (Palm)≥ 0.05mmComplies (≥ 0.05mm)Complies (≥ 0.05mm)
    Physical PropertiesASTM D6319-10(Reapproved 2015)
    Tensile strength (Before aging)≥ 14MPaComplies (≥ 14MPa)Complies (≥ 14MPa)
    Tensile strength (After aging)≥ 14MPaComplies (≥ 14MPa)Complies (≥ 14MPa)
    Elongation (Before aging)≥ 500%Complies (≥ 500%)Complies (≥ 500%)
    Elongation (After aging)≥ 400%Complies (≥ 400%)Complies (≥ 400%)
    Freedom from pinholes21 CFR 800.20 and ASTM D6319-10 (Water leak test)PassedPassed
    Powder ResidualASTM D6319-10 (Test method D5151-06, D6124-06) Acceptance Criteria: < 2 mg/gloveComplies (< 2 mg/glove)Complies (< 2 mg/glove)
    BiocompatibilityISO 10993-10 / ISO 10993-5 (Primary Skin Irritation, Dermal Sensitization, MEM Elution)Passes (Not a primary skin irritant/sensitizer)Passes (Not a primary skin irritant/sensitizer)

    Note: The document distinguishes between white and blue gloves for chemotherapy drug permeation times. For other characteristics, it states "White/Blue Color" and indicates compliance with the same standards, implying similar performance unless specified.

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document does not explicitly state the specific sample sizes used for each individual test (e.g., number of gloves tested for permeation, pinholes, etc.). It refers to compliance with ASTM standards, which would define appropriate sample sizes for those tests.

    • Data Provenance: The tests described are "bench testing" performed presumably by the manufacturer (Ever Global (Vietnam) Enterprise Corporation) or a contracted lab. The manufacturer's address is Vietnam. The testing standards are international (ASTM, ISO) and US federal regulations (21 CFR).

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This question is not applicable as this submission is for medical gloves and not a software/AI device that requires expert ground truth for interpretation. The "ground truth" for the performance criteria is defined by the objective measurements outlined in the referenced ASTM and ISO standards for physical properties, chemical resistance, and biocompatibility.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This question is not applicable as this is not a study involving subjective human interpretation requiring adjudication. Performance is measured against objective standards.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This question is not applicable. This is a submission for a physical medical device (gloves), not an AI/software device.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

    This question is not applicable. This is a submission for a physical medical device (gloves), not an AI/software device.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The "ground truth" for the device's performance is established by objective measurements against recognized international and national standards:

    • ASTM D6978-05: For chemotherapy drug permeation breakthrough times.
    • ASTM D6319-10: For dimensions, physical properties (tensile strength, elongation), and freedom from pinholes (water leak test).
    • 21 CFR 800.20: For freedom from pinholes.
    • ASTM D5151-06 (Reapproved 2015) and D6124-06 (Reaffirmation 2011): For powder residual tests.
    • ISO 10993-10: Third Edition 2010-08-01 and ISO 10993-5: For biocompatibility tests (primary skin irritation, dermal sensitization, MEM Elution).

    8. The sample size for the training set

    This question is not applicable. This is a physical medical device. There is no "training set" in the context of machine learning or AI.

    9. How the ground truth for the training set was established

    This question is not applicable. There is no "training set" or need for "ground truth" establishment in the AI/ML sense for this device. The standards provide the criteria against which the device's physical and chemical properties are measured.

    Ask a Question

    Ask a specific question about this device

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Nitrile Powder Free patient examination glove is a non-sterile disposable device intended for medical purposes that is worn on the examiner's hands or finger to prevent contamination between patient and examiner.

    Device Description

    Disposable Powder Free Nitrile Examination Glove, White/ Blue/ Black/ Pink Color

    AI/ML Overview

    This document is a 510(k) clearance letter from the FDA for a Disposable Powder Free Nitrile Examination Glove. It does not contain information about acceptance criteria or a study that proves a device meets acceptance criteria in the context of an AI/ML medical device.

    The provided text pertains to a Class I medical device (patient examination glove), which typically only requires demonstration of substantial equivalence to a predicate device, not clinical performance studies with acceptance criteria as would be expected for AI/ML devices.

    Therefore, I cannot provide the requested information based on the input text. The questions relating to sample size, data provenance, expert ground truth, adjudication methods, MRMC studies, standalone performance, type of ground truth, and training set details are not applicable to the clearance of a medical glove.

    Ask a Question

    Ask a specific question about this device

    K Number
    K170575
    Date Cleared
    2017-05-16

    (78 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    N/A
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A PATIENT EXAMINATION GLOVES IS A DISPOSABLE DEVICE INTENDED FOR MEDICAL PURPOSE THAT IS WORN ON THE EXAMINER'S HAND OR FINGERS TO PREVENT CONTAMINATION BETWEEN PATIENT AND EXAMINER.

    Device Description

    Not Found

    AI/ML Overview

    Based on the provided text, the document is an FDA 510(k) clearance letter for a Disposable Powder Free Vinyl Exam Glove, Clear/Yellow. This document does not contain any information about an AI/ML-enabled device or its performance criteria and study results.

    Therefore, I cannot extract the requested information regarding acceptance criteria, study details, expert qualifications, or ground truth methods related to an AI device. The document pertains to a physical medical device (gloves) and its substantial equivalence to predicate devices, not the performance of a software or algorithm.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1